Rifampicin Capsule
-
SpecificationCP;BP;USP;IP;Customized
-
Oral Dosage150mg;300mg
-
Dosage FormsCapsules
-
Packing MaterialsALU/PVC Blister
-
Packaging10x2;10x10
-
Active Ingredients:
Rifampicin
Indications:
• Tuberculosis: In combination with other active anti-tuberculosis drugs in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug-resistant cases. Rifadin is also effective against most atypical strains of Mycobacteria.
• Leprosy: In combination with at least one other active anti-leprosy drug in the management of multibacillary and paucibacillary leprosy to effect conversion of the infectious state to a non-infectious state.
• Other Infections: In the treatment of Brucellosis, Legionnaires Disease, and serious staphylococcal infections. To prevent emergence of resistant strains of the infecting organisms, Rifadin should be used in combination with another antibiotic appropriate for the infection.
• Prophylaxis of meningococcal meningitis: For the treatment of asymptomatic carriers of N. meningitidis to eliminate meningococci from the nasopharynx.
• Haemophilus influenzae: For the treatment of asymptomatic carriers of H.influenzae and as chemoprophylaxis of exposed children, 4 years of age or younger.
Storage:
Seal and store in a dry and cool place, protect from light.